Evidence map›Paper›PMID 29480339›Full record

ArticleJournal of community health2018

Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center.

Kaan Z Apaydin, Holly B Fontenot, Derri L Shtasel, Kenneth H Mayer, Alex S Keuroghlian

Open access · greenAbstract read
In one paragraph

Article in Journal of community health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Identifying HPV vaccination research priorities for the US.Human vaccines & immunotherapeutics · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Kaan Z ApaydinThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA.
Holly B FontenotThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA.
Derri L ShtaselHarvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Kenneth H MayerThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA.
Alex S KeuroghlianThe Fenway Institute, Fenway Health, 1340 Boylston Street, Boston, MA, 02215, USA. akeuroghlian@partners.org.
Fenway Health · USBoston College · USLemuel Shattuck Hospital · USMassachusetts General Hospital · US

Funding

Using Mobile Application Strategies to Increase HPV Vaccination Rates among YMSMR21AI130447 · NIAID · BOSTON COLLEGE · PI FONTENOT, HOLLY · 2017 to 2018
$476k
NIAID NIH HHS R21 AI130447
6 · The paper itself

Abstract

Human papillomavirus (HPV) vaccination and anal cancer screening are valuable, yet underutilized, tools in prevention of HPV-related cancers among sexual and gender minority (SGM) populations. The aim of this study was to characterize primary care providers' (PCPs) practices and perceptions pertaining to HPV vaccination and anal cancer screening. A survey assessing self-reported practice characteristics related to HPV vaccination and anal cancer screening, as well as perceived barriers to vaccination and anal cancer screening at the patient-, provider-, and system-level was distributed to PCPs at a Federally-Qualified Health Center that specializes in care for SGM populations in the greater Boston area. A total of 33 PCPs completed the survey. All PCPs strongly recommended HPV vaccination to their patients by emphasizing that the vaccine is extremely important or very important. Most PCPs told their patients that the HPV vaccine prevents cervical cancer (96.9%), anal cancer (96.9%), oropharyngeal cancer (72.7%), penile cancer (57.5%), and genital warts (63.6%). There is substantial variability among providers regarding recommendations for anal cancer screening and follow-up. Most PCPs perceived that patient-level factors such as poverty, mental illness, and substance use disorders were barriers to HPV vaccination and anal cancer screening. Systems-level barriers such as lack of clinical time with each patient and lack of staffing were also described as barriers to vaccination and screening. Patient-, provider- and systems-level improvements are important to increase HPV vaccination and anal cancer screening rates.

Indexed as

Attitude of Health PersonnelAdultAnus NeoplasmsBostonCommunity Health CentersEarly Detection of CancerFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPapillomavirus InfectionsPapillomavirus VaccinesPractice Patterns, Physicians'Primary Health CarePapillomavirus VaccinesCancerHuman papillomavirusPreventionSexual and gender minorityVaccination

Identifiers

PMID29480339
PMCPMC6033675
OpenAlexW2793667892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.